Artem Andrianov, PhD, serves as CEO for Cyntegrity. He graduated with degrees in software engineering, bachelor of economics, and master of business administration.
- Life passion: do clinical trials safer and more efficient, improving clinical research with Risk-based Monitoring (RBM) and drive the concepts of RBM to new frontiers.
- 15+ year of experience in data quality projects, RBM and biostatistics for pharmaceutical industry. Special expertise in such topics as: Spirometry, ECG, Oncology, ePROs, clinical data management.
- In 2013 Artem Andrianov graduated with honors an Executive MBA (Cass, London City University).
- Simultaneously with the study, he founded an innovative company - Cyntegrity, which focuses on data-driven risk management in clinical trials and RBM.